HeartSciences to Merge with Fortitude Mining, Rebrand
TipRanks (Thu, 17-Sep 8:50 AM ET)
Fortitude Appoints Jaime Leverton as Chief Executive Officer
Business Wire (Thu, 17-Sep 8:00 AM ET)
Heart Test Laboratories GAAP EPS of -$0.86 misses by $0.11
Seeking Alpha News (Tue, 15-Sep 9:45 AM ET)
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Globe Newswire (Tue, 15-Sep 9:25 AM ET)
Fortitude Provides Second Quarter 2026 Financial and Operating Highlights
Business Wire (Thu, 20-Aug 7:30 AM ET)
Globe Newswire (Wed, 19-Aug 9:00 AM ET)
Fortitude Completes Acquisition of 12.5 MW Prosser, Nebraska Facility
Business Wire (Tue, 4-Aug 7:30 AM ET)
Business Wire (Thu, 30-Jul 7:30 AM ET)
Globe Newswire (Wed, 29-Jul 9:00 AM ET)
Business Wire (Tue, 28-Jul 7:30 AM ET)
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
Heartsciences trades on the NASDAQ stock market under the symbol HSCS.
As of September 17, 2026, HSCS stock price climbed to $4.09 with 65,691 million shares trading.
HSCS has a beta of -0.54, meaning it tends to be less sensitive to market movements. HSCS has a correlation of 0.01 to the broad based SPY ETF.
HSCS has a market cap of $19.63 million. This is considered a Sub-Micro Cap stock.
Last quarter Heartsciences reported $2,100 in Revenue and -$.86 earnings per share. This fell short of revenue expectation by $-17,900 and missed earnings estimates by -$.13.
In the last 3 years, HSCS traded as high as $85.18 and as low as $1.63.
The top ETF exchange traded funds that HSCS belongs to (by Net Assets): VXF.
HSCS has outperformed the market in the last year with a price return of +17.9% while the SPY ETF gained +16.6%. HSCS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +116.4% and +35.9%, respectively, while the SPY returned +1.8% and -0.4%, respectively.
HSCS support price is $3.52 and resistance is $4.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HSCS shares will trade within this expected range on the day.